JAYENDRAKUMAR D. PATEL,
Chief Executive Officer and Director
Pyrrhic Pharma Private Limited, India
Dr. Srikanth Boinapally, Researcher The Johns Hopkins University, USA
PROFESSOR, Biomedical Sciences
Universitatii Street, Romania, Romania
Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at email@example.com
Research in Pharmaceutical sciences has become multidisciplinary in nature and yielding a great benefit to the medical community and the society. The subject at present consists of numerous subjects in which Drug Delivery claims higher significance. Drug Delivery approaches have become multidisciplinary in nature and encompass a number of disciplines and sub disciplines within the broader scope of the topic. Various important topics including dosage forms, controlled release, drug absorption, ADMET, bioavailability, Nano medicine, Gene based delivery and therapy, drug designing and delivery, long term and short term impact of specific delivery issues, associated disease scenario, relation of drug delivery and diseases etc.
American Journal of Advanced Drug Delivery (ISSN: 2321-547X) is an Open Access peer reviewed journal published the first issue in 2013. This journal follows a strictly peer review process to maintain the standard of the articles.
The Journal is having wide indexing in: NLM ID: 101731920; Google Scholar, ICMJE, SHEPRA/ROMEO, Genamics, International Society of Universal Research in Sciences, academia.edu, Pak Directory of Open Access Journals, Research Bible, Scientific Journal Impact Factor, Open Academic Journal Index, Jour Informatics, Index Copernicus, Cite SeerX, Gold Rush and Global Impact Factor.
The present Global Impact and Quality Factor of American Journal of Advanced Drug Delivery is 0.786.
Submit manuscript at Online Submission System or send as an e-mail attachment firstname.lastname@example.org
Major Topics covered include:
Fast Editorial Execution and Review Process (FEE-Review Process):
American Journal of Advanced Drug Delivery is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in American Journal of Advanced Drug Delivery have been cited by esteemed scholars and scientists all around the world. American Journal of Advanced Drug Delivery has got h-index 19 , which means every article in American Journal of Advanced Drug Delivery has got 19 average citations.